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Abstract 
The TRiC (TCPl Ring Complex) chaperonin complex participates in the functional folding of actin, centractin, a-,/J-, y-tubulin, and phytochrome. 
Each of the cytoskeletal proteins contain a peptide, RK(A,C,T)F/KRAF, located towards the C-terminus, which is homologous to a TCPld peptide, 
while the equivalent phytochrome peptide (RLKAF in certain isoforms) is very similar to the KLRAF peptide of TCPla. We propose that this TCPla 
peptide binds to the nascent polypeptides as they emerge from the ribosome, that this binding restricts the folding pathway, and that the TCPla 
peptide is subsequently displaced by the synthesis of the consensus peptide. This hypothesis is strongly supported by the crystallographic structure 
of actin. 
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1. Introduction 
The a-, j?-, and y-tubulins are each highly conserved, 
and the three sub-families share 30-35% sequence iden- 
tity [l]. Similarly, actin and centractin are about 50% 
identical [2,3]. By contrast, the homologies between 
members of the tubulin and actin families are restricted 
to a small number of peptides, most of which (such as 
a glycine-rich peptide) are common to many nucleotide- 
binding proteins. There is, however, increasing evidence 
that the synthesis of natively-folded a-, j?-, and y-tubulin, 
actin and centractin, and a number of other proteins 
(including phytochrome [4]) each require TCPl, a con- 
stituent protein of a cytoplasmic chaperonin, while a 
TCPl-like protein has been implicated in the assembly 
of the hepatitis B virus capsid protein [5]. 
Synthesis of a- and/I-tubulins in an E. coli lysate yields 
assembly-incompetent protein, yet the protein produced 
in a reticulocyte expression system can be co-assembled 
with carrier tubulin into bone fida microtubules [6,7]. 
Reticulocyte component(s) therefore appear to facilitate 
the functional folding of the nascent tubulin polypep- 
tides. Indeed, the reticulocyte-expressed /I-tubulin can be 
fractionated by either ion exchange or gel filtration 
chromatography into three components, one of which 
has an apparent molecular weight in excess of 900 kDa, 
and monomeric tubulin subunits can be chased from this 
aggregate component by the inclusion of MgZ’ - ATP 
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[7,8]. Similarly, bacterially expressed actin is also assem- 
bly-incompetent, yet the functional folding, assayed by 
assembly, DNase I-binding, or electrophoretic mobility, 
can be restored by denaturation followed by incubation 
with Mg2’ - ATP and a 19s polymeric aggregate present 
in reticulocyte lysates [9]. Similar studies have estab- 
lished that the reticulocyte component also facilitates the 
correct folding of centractin and y-tubulin [lo], and of 
phytochrome [4]. Furthermore, immature assemblies of 
the hepatitis B core protein, on expression in a wheat 
germ translation system, crossreact with a polyclonal 
antibody raised against a TCPl peptide, although a 
TCPl-like protein was apparently not bound to either 
the expressed monomer or the dimer [5]. 
The functional component has been purified from 
reticulocyte lysates, from bovine testis, and tissue culture 
cells [9,1 l-131, and in each case it is a toroidal structure 
consisting of stoichiometric amounts of a number of 
related proteins. As one of these proteins crossreacts 
with anti-TCPl antibodies, the purified ring-like struc- 
ture has been termed TRiC (TCPl Ring Complex, [ 111). 
Both the bovine testis TRiC and the purified reticulocyte 
19s component (plus additional co-factors) effect the 
MgZ’ * ATP-dependent refolding of guanidinium chloride 
denatured a- and j?-tubulin [ 11,13,14]. Furthermore, the 
900 kDa TRiC complex has been implicated in the fold- 
ing of actin and tubulin in vivo [ 151. In summary, there 
is persuasive vidence that TRiC functions as a chaper- 
onin in effecting the functional folding of actin, cen- 
tractin, the tubulins, and phytochrome, and that the 
wheat germ equivalent may be involved in the assembly 
of capsids from the hepatitis B core protein. While these 
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activities might relate to any of the constituent TRiC 
proteins, the antibody studies and a mutation of the 
yeast TCPlcl protein, which affects microtubule-depend- 
ent processes [16], strongly suggest he direct involve- 
ment of TCPl. 
2. Comparison of primary sequences 
The 900 kDa TRiC complex contains about nine pro- 
teins, six or seven of which are highly homologous 
[12,17]. Seven mouse TCPl homologues, termed 
TCPbz-TCPlq or CCTcx-CCTq (for Chaperon Con- 
taining TCPl) have been sequenced ([17]; Table 1). Hom- 
ologues to the mouse TCPlol have been sequenced from 
rat, CHO, human, Drosophila, S. cerevisiae, and Arab- 
dopsis (see Table 1). More divergent sequences, but 
which still resemble TCPla, have been identified in 
Avena sativa and in S. cerevisiae (Table 1). 
One peptide of the TCPlol family (mouse TCPlcc:487- 
496) is strikingly similar to an c+tubulin peptide 
(IX-Tu: 396-406, Table 2). The two peptides are identical 
at eight of the eleven positions, provided a single gap is 
inserted into the a-tubulin and two into the TCPl& se- 
quence, and nine out of eleven residues if a conservative 
(methionine/valine) amino acid substitution is also ac- 
cepted. The a-tubulin peptide is extremely highly con- 
served (Fig. lA), while the TCPla peptide Leu488-Arg4g3 
is conserved in each of the available sequences, making 
it one of only seven totally conserved peptides of six or 
more residues. 
Inspection of the /I- and y-tubulin peptides equivalent 
to a-Tu: 396406 show that they are also highly con- 
served and show homology with the TCPlcl peptide (Fig. 
1B and C; Table 2). Insertion of two gaps into both the 
Table 1 
Comparison of the available TCPl sequences, showing the peptide 
(TCPla:486498 for the mouse sequence) postulated to in- 
teract with th nascent polypeptide. 
Mouse TCPla 
Rat TCPl 
CHO TCPl 
Human TCPl 
Drosophila TCPl 
S. cersvisise TCPla 
Arabdopsis TCPl 
Mouse TCPl I3 
Mouse TCPly 
Mouse TCPlG 
Mouse TCPle 
Mouse TCPl c 
Avena sativa TCPl 
Mouse TCPlq 
S. cerevisiae TCPI 13 
1171 
Ki 261 
t;; 
1271 
The upper half shows the mouse TCPla and homologues from rat, 
CHO cells, human, Drosophila, S. cerevisiae, and Arabdopsis, while the 
lower half shows the more divergent mouse TCPlS_mouse TCPlg 
isoforms and the additional sequences from Avena sativa and S. cerevi- 
siae. Residues which are identical to those of mouse TCPla are boxed. 
Table 2 
Paired comparison of the consensus peptides of a-, /7-, and y-tubulin 
(a-Tu: 394410, j?-Tu: 384400, and y-Tu: 39UlO), actin (AC: 364- 
375), centractin (CAc: 365-376), and phytochrome A (P: 897-905) with 
TCPl:484500 of murine TCPla. 
The discussed homologies are restricted to a-Tu: 396406, /S-Tu: 386 
396, y-Tu:396-406, Ac:369-375, CAc:371-376, P:895-899 and 
TCPla:487496; the flanking residues are shown to illus- 
trate the lack of significant homology elsewhere within the sequences. 
The heavy boxes identify residues which are identical in each peptide 
pair, while the light boxes highlight conservative amino acid substitu- 
tions. Two types of insertion are shown: (.) has been introduced into 
a- and /I-tubulin, actin, centractin, phytochrome A and TCPl to align 
these sequences with y-tubulin. (-) shows insertions introduced to max- 
imize the homology between each peptide pair. The small number of 
y-tubulin sequences leads to some ambiguity in identifying the consen- 
sus residue, as indicated by the lower case symbols. 
p-tubulin @-Tu: 386396) and the TCPla peptides 
results in identity at four out of eleven positions, and 
acceptance of conservative amino acid substitutions 
(lysine/arginine, leucine/alanine, valine/methionine) 
increases this homology to eight out of eleven residues. 
The y-tubulin sequence (y-Tu:39&406) reveals addi- 
tional degeneracy: it is necessary to introduce three in- 
sertions into both the y-tubulin and the TCPla se- 
quences (Table 2). Following this alignment, the y-tu- 
bulin and TCPlcc peptides are identical at six out of nine 
positions. The degeneracy is even more pronounced in 
Chlamydomonas rheinhardtii, in that the y-sequence con- 
tains a unique, four residue insertion (PKQE at 
y-Tu : 405/406; C Silflow, personal communication). 
The common feature of the homologies between 
TCPla and the three tubulin sub-families is the motif 
KRAF or RKAF, supplemented by various N-terminal 
residues and (in a- and /3-tubulin) by a highly conserved, 
C-terminal histidine. The homology is particularly strik- 
ing between TCPla and a-tubulin, less evident in 
jj-tubulin, and least in y-tubulin. Indeed, the y-tu- 
bulin : TCPla: homology largely depends upon the align- 
ment of the three tubulin sub-families [ 11. There is conse- 
quently a variable level of degeneracy between TCPla 
and the individual members of the tubulin family, al- 
though the KRAF or RKAF motif remains a common 
feature. 
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KFDLYYAKRAFVHWYVC 
QFTAYPRRKAFLHWYTG 
QYDKLRKRNAFLEQFRK 
1.5 
1 Actin I 
SGPSIVHRKCF 
Residue 
Fig. 1. Comparison of the Conservation Index of a-Tubulin (a- 
Tu:394410, 55 sequences), j%Tubulin @-Tu:384-400, 70 sequen- 
ces), y-Tubulin (y-Tu:394-410, 8 sequences), and actin (AC: 
36S375, 99 sequences). The Conservation Index at each residue posi- 
tion is calculated as (n,’ + nz2 + . ..)/p. where N is the total number of 
known sequences of each individual protein and a,, n,, . . . are the 
number of these sequences with a specific amino acid at the specified 
position [33]. This Index, which for an inlinite sixed sample varies 
between 0.05 and 1.0, differs from the more conventional calculation 
of determining the fraction of the sequences with the consensus residue. 
In particular, it mi ’ mm&es the contribution of single residue differences, 
which may be due to a sequencing error, and increases the significance 
of a specific amino acid substitution when it occurs in several sequences. 
For instance, the low Conservation Index of a-Tu: A400 (0.743) is due 
to an alaninekerine substitution in 6 out of 55 sequences, plus single 
lysine and glycine substitutions. The low Conservation Indices of y- 
tubulin is due to the availability of only 8 phylogenetically diverse 
sequences. 
The actin sequence lacks this motif. It does however 
terminate in the highly conserved RKCF C-terminal 
peptide (Table 2, Fig. 1D). This sufficiently resembles, 
with its conservative alanine/cysteine substitution, the 
tubulin peptides to suggest hat it is homologous with the 
TCPlcl KLRAF peptide, particularly since it requires 
the common insertion corresponding to the TCPla : L492. 
This homology is increased by considering the three 
amino acids N-terminal to this motif to six out of seven 
residues, provided that an additional conservative (leuc- 
ine/isoleucine) substitution, is accepted (Fig. 1D). Fur- 
thermore, as the C-terminal peptide of actin adopts an 
&-helical conformation, the AC: H3’i residue may be 
quasi-equivalent to the highly conserved histidine resi- 
dues of a- and /I-tubulin (cx-Tu:H~ and /I-Tu:H~~~), 
such that it can also contribute to the homology with 
TCPla. A similar argument applies to centractin (Table 
2), in that its C-terminal peptide is identical to that of 
actin, except for the CAc : T375/Ac : A374 substitution, has 
a similarly conserved histidine, and in common with the 
actin and tubulin alignments it is necessary to introduce 
an insertion corresponding to TCP 101: L492. The presence 
of a modified motif in phytochrome A will be considered 
later. 
In summary, a-tubulin, /I-tubulin, y-tubulin, actin, 
and centractin each contain a highly conserved sequence 
which is homologous to a TCPl a peptide. The consensus 
peptide, of which the key residues are RK(A,C,T)F or 
KRAF, will be referred to as the C-Peptide (for consen- 
sus/C-terminal peptide), while the quasi-equivalent 
TCPlcl peptide will be referred to as the TCPlol homo- 
logue. Using the amino acid compositions of human a-, 
/I-, and y-tubulin, actin, centractin and TCPlcx to calcu- 
late the probabilities of these proteins containing the 
C-Peptide or the TCPlat homologue yield values of 3.15, 
2.44, 0.48, 0.54, 3.22, and 4.06 x 10m3, respectively. Cal- 
culation of the probability that the tubulin, actin, and 
TCPlcl families (as represented by the human a-tubulin, 
actin, and TCPl& proteins) would each contain a related 
peptide, defined as KR(A/T/C)F or RKAF, yields a 
value of 184 x 10V9. This strongly suggests that the com- 
mon presence of the related peptides is not adventitious. 
Inspection of the GenBank protein database with the 
FindPattern algorithm for proteins containing the 
RK(A,C,T)F or KRAF peptides yielded 535 sequences 
(out of 3 1,808), of which 212 corresponded to either actin 
or the tubulins. The 323 sequences which encoded nei- 
ther actin nor tubulin represented 207 different proteins 
or hypothetical proteins. This compares with the 222 
predicted sequences, based upon the frequency of occur- 
rence of the individual amino acids [28] and the total 
length of the searched sequence (10,792,076 residues 
after omission of the over-represented actins and tu- 
bulins). The motifs are therefore slightly more common 
in the current database than the predicted frequencies 
(323 vs. 222), despite the removal of the over-repre- 
sented, and highly conserved, actins and tubulins. 
3. TCPla and protein folding 
Chaperonins, including TRiC, probably assist in pro- 
tein folding by binding to particular, and in general hy- 
drophobic, peptides and so prevent certain kinetically 
favourable peptide :peptide interactions which would re- 
sult in the nascent protein adopting an anomalous terti- 
ary structure. A similar mechanism presumably applies 
to the chaperonin-mediated assembly of multisubunit 
complexes. The limitation on the folding pathway is 
transitory, and is relieved by further extension of the 
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Fig. 2. Schematic of the proposed model, showing an elongating nascent polypeptide chain emerging from four sequential ribosomes. A peptide, 
located close to the N-terminus of the nascent polypeptide, is identified as the A-Site, and is shown as an open box. This is recognised by the TCPla 
peptide (shown as a filled box on the shaded chaperonin complex), which prevents the anomolous folding of the emerging polypeptide (shown in 
the left-hand two of the ribosomes). As translation of the nascent polypeptide continues, a peptide is synthesized which is termed the C-Peptide and 
which is shown as a fYled box (see third ribosome). The C-Peptide is homologous to the TCPla peptide, and it displaces the TCPla from the A-Site, 
so allowing the emerging polypeptide to adopt its native conformation (shown as a four-leaf clover leaf, right-hand ribosome). The released chaperonin 
complex is then available to facilitate the folding of another nascent polypeptide chain. 
nascent polypeptide from the ribosome, coupled with 
chaperonin-mediated ATP hydrolysis, which presuma- 
bly induces a conformational change and the consequen- 
tial release of the chaperonin from the correctly folded 
protein. The need to restrict the folding pathway may 
apply in particular to those proteins which have a com- 
plex topology reflecting the functional demands of the 
folded protein. Consequently, the involvement of the 
TRiC complex in the folding of tubulin and actin may 
be determined, in part, by the needs to self-assemble into 
microtubules and actin filaments, and to undergo a con- 
formational change in response to the assembly-depend- 
ent hydrolysis GTP or ATP. Similarly, the role of the 
TRiC complex in the folding of phytochrome may reflect 
the structural demands of the photoactivated conforma- 
tional change. 
The identification of the C-Peptide of d-, /I-, and y- 
tubulin and of actin and centractin suggests a molecular 
mechanism for releasing of TCPlcl from the newly 
folded polypeptide. We propose that the TCPlcc homo- 
logue binds to one or more peptides, termed the A-Site, 
which lie nearer the N-terminus of the nascent polypep- 
tide than the C-Peptide, and that this prevents the 
anomalous folding of the protein as it emerges from the 
ribosome. We further propose that when the C-Peptide 
is subsequently synthesized that the constrained folding 
pathway positions this peptide such that it competes with 
the TCPla homologue, and that this results in the dis- 
placement of TCPla from the correctly folded polypep- 
tide. This model is shown in Fig. 2. 
A number of factors may aid the competition between 
the C-Peptide of the nascent chain and the TCPlol pep- 
tide, including a higher affiity of the native C-Peptide 
for the A-Site than the TCPl& homologue. Significantly, 
the identified C-Peptides of actin, centractin, 01-, /I-, and 
y-tubulin resemble but are not identical to the TCPl& 
homologue peptide in that they each lack the residue 
equivalent o TCPl a : L4g2. 
This model is consistent with the tertiary structure of 
actin [29-311. The N-terminus lies within s&domain-l, 
but only two anti-parallel p-pleated sheets are completed 
before the formation of subdomain-2. The polypeptide 
chain then re-enters subdomain-l and forms a sheet/ 
helix/sheet motif (AC: 105-109, AC: 115-128, AC: 133- 
138), before exiting to form subdomains- and -4. The 
polypeptide chain then re-enters sub-domain-l and 
forms the four C-terminal a-helices (Ac:337-350, 
AC: 355-357, AC: 361-367, and AC: 370-375). The com- 
plexity of this topology highlights why the TRiC, or 
another, chaperonin may be required in order to restrict 
the folding pathway. 
Inspection of the actin : gelsolin tertiary structure [30] 
shows that the RKCF-containing Ac:370-375 a-helix 
abuts a surface formed from residues of the AC : 115-128 
cc-helix and the AC: 133-138 B-pleated sheet. There are 
four close associations, defined as being of less that 481, 
between the main chain carboxyls of AC: K373, C374, F3” 
and Ac:R’16 or Ac:Y’~~, and a further eight close associ- 
ations involving the sidechains (AC: C374 with AC: R’ 16, 
Ac:Y’~~ and AC: VIM; AC: F3” with Ac:Y16’ of 
subdomain-3; and Ac:H3”, see above, with Ac:K113, 
Rn6, En’). These close contacts strongly suggest that 
A-Site is formed from the residues AC: 115-l 17 and 
AC: 133-134. Each of the identified A-Site residues 
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(Ac:K113, R”‘j, En’, Y133, and V13’) are highly 
conserved (Conservation Indices: 0.98, 1.00, 1.00. 0.98, 
and 0.98, respectively). 
Chaperonins are generally considered to protect hy- 
drophobic peptides during protein folding. While the 
A-Site residues Ac:K113, R116 and E”’ are highly 
charged, AC : Y 133 and Ac:V’~~ lie within an extremely 
hydrophobic peptide which probably requires protection 
from the solvent until becoming masked by the subse- 
quent synthesis of the C-terminal C-Peptide. We propose 
that this protection is effected by the interaction with the 
TCPla homologue peptide. 
Numerous studies have demonstrated the high chemi- 
cal reactivity of Ac:C~‘~ (see [32]) yet the crystallogra- 
phic structure shows that this residue is buried and is not 
exposed to the solvent. The C-Peptide may therefore 
exhibit some kinetic flexibility, and this may be required 
to facilitate the release of the TCPla homologue peptide. 
The mechanism of this release may also account for the 
high conservation of Ac:R3” despite the structural evi- 
dence that it is exposed to the surface and is not in close 
contact with any other residue. 
The sequence homology of actin and centractin 
strongly suggests that the two proteins have closely re- 
lated tertiary structures. Consequently, the proposed 
model probably also applies to the folding of centractin. 
The CAc : T3”/Ac : C374 substitution is of particular inter- 
est in view of the number of close associations between 
Ac:C”~ and the A-Site residues. Significantly, the cen- 
tractin A-Site contains two conservative substitutions 
133 (CAC:F’~~/AC:Y , CAc: 1134/Ac : V13’), and additional 
flanking residue differences, which may compensate for 
the C-Peptide difference. The C-Peptides of the tubulins, 
which each lie towards the C-terminus of the individual 
sequences, are similarly proposed to compete for the 
TCPla homologue peptide during the folding of the nas- 
cent polypeptides, and to interact in the native proteins 
with peptides equivalent to those forming the A-site of 
actin. The absence of the tubulin crystallographic struc- 
ture precludes the direct identification of these additional 
peptide( 
The homology between TCPla and the other proteins 
focuses on the identified RK(A,C,T)F/KRAF motif 
(Table 2). The protein-specific variations would indicate 
that the selective pressures on the individual C-Peptide 
residues may differ between the three tubulin classes and 
between actin and centractin, and that the sequences are 
not determined exclusively by the functional require- 
ments of the interaction with the TCPla homologue pep- 
tide. Indeed, the conservation of the AC: R372, AC: K373 
and AC: F3” (Fig. 1) may be de&red in part by their role 
in specifying the profilin-binding site [30]. Such ‘dual 
selective pressures’ may also account for the reported 
requirement for two unidentified co-factors in the fold- 
ing of a- and j&tubulin but not of either y-tubulin or 
centractin [ 10,13,14], and undoubtedly contribute to the 
remarkable conservation of the individual tubulin and 
actin sequences [32,33]. 
4. The speelflelty of TCPl 
Only the vertebrate TCPla sequences contain the 
KLRAF peptide: 5’. cerevisiae, Drosophila, and Arab- 
dopsis TCPla sequences contain the variants KLRSY 
and KLRAY (Table 1). Assuming that the interaction 
between the TCPla homologue peptide and the nascent 
actin polypeptide mimics that between the C-Peptide and 
the A-Site of actin, then TCP~X:A~~~ would be antici- 
pated to make sidechain interactions with Ac:R116, 
Ac:Y’~~ and Ac:V’~. The TCP~X:S~~~ substitu- 
tion of S. cerevisiae and Drosophila is not compensated 
by substitution(s) within the actin A-Site. Consequently, 
subtle differences elsewhere within the non-vertebrate 
TCPla sequences may, as discussed for the AC: C374/ 
CAc: T374 substitution, confer a specific advantage to this 
TCPla alaninelserine substitution. The S. cerevisiae, 
Drosophila, and Arabdopsis TCPla sequences each con- 
tain the TCPla: F495 to TCPla: Y495 substitution, which 
the actin crystallographic structure would imply inter- 
acts with AC: Y169 of subdomain 3 until the eventual 
synthesis of the actin C-Peptide. Significantly, the yeast 
and one of the Drosophila actin isoforms both contain 
the complimentary substitution (Ac:Y1’j9 to AC: F’@), in- 
dicating the apparent conservation of the atomic interac- 
tions between the TCPla homologue and the nascent 
actin polypeptide. 
In vitro and in vivo evidence both highlight the impor- 
tance of TRiC in the functional folding of proteins of the 
actin and tubulin families, while the effects of a Sac- 
charomyces TCPla mutation on microtubule-dependent 
processes indicate that the TCPla gene product plays an 
essential role [16]. 
Inspection of the protein database showed that slightly 
more sequences contain the TCPla C-Peptide motif than 
would be statistically predicted. The proposed role of the 
C-Peptide motif places it towards the C-terminus of the 
peptide sequence requiring an interaction with TCPla 
for its functional folding (see Fig. 2). The consensus 
peptide lies at a mean position of 0.506 + 0.301 from the 
N-terminus in the 207 identified proteins. The presence 
of this peptide may not therefore be diagnostic of an 
involvement of the TCPla complex in the folding of the 
specific nascent polypeptide. Alternatively, the TCPl a 
complex may contribute to the folding of specific struc- 
tural domains, with the C-Peptide lying towards the 
C-terminus of the sequence specifying this domain. 
The heterogeneity within the C-Peptide residues of a-, 
fi-, and y-tubulin, and actin and centractin, coupled with 
the subtle differences between the TCPla homologous 
peptide from different organisms, shows that the pro- 
posed mechanism by which the TCPla homologous pep- 
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tide transiently protects the A-Site is not absolutely con- 
served. This is amply illustrated by phytochrome, since 
this is a protein which requires the TRiC complex for its 
folding [4] but is not identified by the motif screening. 
Significantly, the sequences of three of the Class A 
phytochromes contain the peptide RLKAF (Table 2, 
residues P:895-899). This is strikingly similar to the 
KLRAF sequence of the TCPla homologue peptide. 
The calculated probability of occurrence, using the 
Avena sativa phytochrome A, Type 4 sequence, is 
1.13 x 10M3. While oz-, j?-, and y-tubulins, actin, and cen- 
tractin each lack the leucine residue corresponding to 
TCPlcl : L492, the phytochrome A sequences lack the 
C-flanking histidine residue which possibly contributes 
to the homology between TCPlol and several of the cy- 
toskeletal proteins. The probability that phytochrome A 
would have the RLKAF and that TCPlcl would have the 
KLRAF peptide is 0.41 x 10e6. Other Class A phyto- 
chromes have related sequences (eg RLKAL and 
RLKVL in Arabdopsis thaliana and Pisum sativum) 
yielding, for the five available phytochrome A sequences, 
a Conservation Index of 0.84. The Class B and Class C 
phytochromes are, in common with the observed differ- 
ences between a-, j?-, and y-tubulins, more divergent. 
Significantly, the phytochrome A RLK(A,V)(F,L) pep- 
tides lie close to the C-terminus (at 0.79), i.e. their loca- 
tion is fully consistent with the proposed model (Fig. 2) 
of how the TRiC complex effects the functional folding 
of a nascent polypeptide. By contrast, the hepatitis core 
protein lacks any peptide which is clearly homologous to 
this C-Peptide motif. Significantly, the TCPl-like protein 
appears to be involved in the assembly of the core pro- 
teins into a capsid rather than in the folding of the 
monomeric core subunit [5], such that the C-Peptide 
motif may be defined by an interface between two mon- 
omeric core subunits. 
The identification of the C-Peptide in the tubulins, 
actins and phytochrome A relies upon the homologies 
with TCPlol. Six other members of the TCPl (or CCT) 
family have been identified in mouse (Table 1, [ 17]), and 
additional homologues in Avena sativa [27] and S. cere- 
visiae [25]. These isoforms each differ from TCPla 
within the peptide homologous to the identified C-Pep- 
tide (Table l), which indicates that they are not involved 
in the folding of the tubulins, actins, or phytochrome A. 
As each TRiC complex contains multiple subunits, the 
variety of TCPl isoforms may result in the formation of 
a family of TRiC complexes, which range from ones 
containing a single isoform to ones formed from a mix- 
ture of isoforms. Indeed, the complexes, purified from 
rat and guinea pig brain and testis have differing compo- 
sitions [34]. The differences in the homologous peptides 
of the difference TCPl isoforms (Table 1) may define 
which particular eucaryotic proteins require which spe- 
cific TRiC complex for their functional folding. Indeed, 
TCPl has been implicated in the folding of firefly lucif- 
erase [l 11, although the efficacy was not been reported: 
the firefly luciferase sequences lack a peptide resembling 
the TCPl& homologue. The eucaryotic luciferase se- 
quences do however contain the peptide KRLR, which 
closely resembles the homologous peptide of mouse 
TCPlrj (KLRAR, Table 1). The KRLR sequence is lo- 
cated close to the C-terminus (at 0.93) and, in common 
with several other identified C-Peptides, lacks the residue 
equivalent to the mouse TCPla : L492. The specific se- 
quences of the individual members of the TCPl family 
corresponding to the TCPlcl homologous peptide may 
therefore specify which TRiC complex binds to the nas- 
cent polypeptide chain. This may also apply to other 
chaperonins, including the chaperonin-like protein of the 
archaebacterium Sulfobolus TF55, which shares a 36% 
identity with TCPla but which contains the QLRSL 
sequence in place of the TCPlol KLRAF motif. 
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